WHITEHAWK THERAPEUTICS, INC. Convertible Notes Payable, Noncurrent
WHITEHAWK THERAPEUTICS, INC. (WHWK) had Convertible Notes Payable, Noncurrent of $1.10 million as of 2020-12-31, per its 10-K filed 2022-03-17.
Discontinued › Balance Sheet › Liabilities
us-gaap:ConvertibleLongTermNotesPayable · last filed 2022-03-17
- 2020-12-31: Convertible Notes Payable, Noncurrent $1.10M.
| Period end | Convertible Notes Payable, Noncurrent |
|---|---|
| 2020-12-31 | $1.10M 10-K · filed 2022-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |